Cytochalasin C
(Synonyms: 细胞松弛素C) 目录号 : GC14420An actin polymerization inhibitor and fungal metabolite
Cas No.:22144-76-9
Sample solution is provided at 25 µL, 10mM.
Cytochalasin C inhibits actin polymerization.
The cytochalasins are cell-permeable fungal metabolites inhibiting actin polymerization. This interferes with such diverse processes as cell growth, movement, phagocytosis, degranulation, as well as secretion.
In vitro: Previous study described the first results of actin assembly assays in the presence of the different cytochalasins. Acceleration of actin assembly in the presence of several cytochalasins was apparent from the more extensive assembly at shorter times. Cytochalasin C and its analogs, cytochalasin D, H, and J made up the same Group, which was characterized by fast assembly, so that the extent of assembly was reached before the first FPR data trace could be obtained, less than 4 min into the reaction. Thus, the members of this group including cytochalasin C were both strong accelerators of assembly and also inhibitors of steadystate extent of assembly.Moreover, cytochalasin C and D were found to be much stronger inhibitors than cytochalasin H and J, which were moderate and weak inhibitors, respectively. In addition, the effects of these cytochalasins on the diffusion coefficients of actin filaments at steady state was also have examined. Results showd that cytochalasin D and H had significantly higher diffusion coefficients. In contrast, cytochalasin C and cytochalasin A, B, J displayed a weak shortening activity [1].
In vivo: In zebrafish, cytochalasin D at 0.2 μM gave an approximate LD50, while cytochalasin B was fully tolerated at 5 μM, and gave an LD50 of 10 μM. Cytochalasin C was tolerated fully at 1 μM, which was ten-fold higher than the level for cytochalasin D that was tolerated [2].
Clinical trial: Up to now, there is no clinical data reported.
References:
[1] Walling, E. A.,Krafft, G.A. and Ware, B.R. Actin assembly activity of cytochalasins and cytochalasin analogs assayed using fluorescence photobleaching recovery. Archives of Biochemistry and Biophysics 264(1), 321-332 (1988).
[2] Trendowski M, Wong V, Wellington K, Hatfield S, Fondy TP. Tolerated doses in zebrafish of cytochalasins and jasplakinolide for comparison with tolerated doses in mice in the evaluation of pre-clinical activity of microfilament-directed agents in tumor model systems in vivo. In Vivo. 2014 Nov-Dec;28(6):1021-31.
Cas No. | 22144-76-9 | SDF | |
别名 | 细胞松弛素C | ||
化学名 | (3S,3aR,6S,6aR,7E,10S,12R,13E,15R,15aR)-15-(acetyloxy)-3,3a,6,6a,9,10,12,15-octahydro-6,12-dihydroxy-4,5,10,12-tetramethyl-3-(phenylmethyl)-1H-cycloundec[d]isoindole-1,11(2H)-dione | ||
Canonical SMILES | O[C@H]1[C@H]2[C@@]3([C@@H](/C=C/[C@@](C)(O)C([C@@H](C)C/C=C/2)=O)OC(C)=O)C([C@H](CC4=CC=CC=C4)NC3=O)C(C)=C1C | ||
分子式 | C30H37NO6 | 分子量 | 507.6 |
溶解度 | Soluble in ethanol;Soluble in methanol;Soluble in DMSO;Soluble in dimethyl formamide | 储存条件 | Store at -20°C |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 1.9701 mL | 9.8503 mL | 19.7006 mL |
5 mM | 0.394 mL | 1.9701 mL | 3.9401 mL |
10 mM | 0.197 mL | 0.985 mL | 1.9701 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet